Chronic Kidney Disease

EASD 24: Prespecified Analysis from the SELECT Trial

Helen Colhoun

Watch time: 5m 37s
FLOW: Kidney, Cardiovascular, Mortality, Metabolic and Safety Results

Richard Pratley

Watch time: 6m 39s
ESC 24: FINE-HEART: Finerenone in HF & CKD

Muthiah Vaduganathan

Watch time: 4m 24s
ADA 24: FLOW Trial: Kidney Outcomes in Patients Treated with Semaglutide

Vlado Perkovic

Watch time: 5m 40s
Importance of Testing for CKD Among Patients With Type 2 Diabetes

Pam Taub, Nikolaus Marx

Watch time: 10m 51s
HFA 24: FINE-HEART: Design & Baseline Characteristics

Muthiah Vaduganathan

Watch time: 4m 40s
HFA 24: Timing of Cardio-Kidney Protection with SGLT2i

Muthiah Vaduganathan

Watch time: 5m 24s
IMPACT CKD: 10-year Outlook on CKD

Jerome Rossert

Watch time: 5m 22s
CardioNerds @AHA23: Presidential Advisory on CKM Health

Ramy Doss, Chiadi Ndumele

Watch time: 14m 32s

James Burton, Shelley Zieroth, Andrew Frankel et al

Watch time: 1h 34m (7 videos)

Fausto J Pinto, John Spertus et al

Radcliffe & CardioNerds @AHA22: EMPA-Kidney: Empagliflozin & CV Outcomes in Patients with Chronic Kidney Disease

Kate Wilcox, David Preiss

Watch time: 18m 1s

David Wheeler, Carol Pollock et al

Muthiah Vaduganathan

Andrew JS Coats, Stefan Anker

James Burton, Shelley Zieroth, Andrew Frankel et al

Watch time: 1h 34m (7 videos)

Fausto J Pinto, John Spertus et al

Debbie L Cohen , Raymond R Townsend

Paul Kalra

Watch time: 12m 41s (2 videos)
Importance of Testing for CKD Among Patients With Type 2 Diabetes

Pam Taub, Nikolaus Marx

Watch time: 10m 51s

Karthiek R Narala , Thomas A LaLonde , Sohail Hassan , et al

ACC 22 Late-breaker Discussion: The DIAMOND Trial

Harriette Van Spall, Javed Butler, Faiez Zannad, et al

Watch time: 22m 47s
HFA 24: FINE-HEART: Design & Baseline Characteristics

Muthiah Vaduganathan

Watch time: 4m 40s

Media

Andrew JS Coats, Stefan Anker

EASD 24: Prespecified Analysis from the SELECT Trial

Helen Colhoun

Watch time: 5m 37s

David Wheeler, Carol Pollock et al

Muthiah Vaduganathan

ACC 22 Late-breaker Discussion: The DIAMOND Trial

Harriette Van Spall, Javed Butler, Faiez Zannad, et al

Watch time: 22m 47s

Fausto J Pinto, John Spertus et al

James Burton, Shelley Zieroth, Andrew Frankel et al

Watch time: 1h 34m (7 videos)
FLOW: Kidney, Cardiovascular, Mortality, Metabolic and Safety Results

Richard Pratley

Watch time: 6m 39s
Importance of Testing for CKD Among Patients With Type 2 Diabetes

Pam Taub, Nikolaus Marx

Watch time: 10m 51s
Radcliffe & CardioNerds @AHA22: EMPA-Kidney: Empagliflozin & CV Outcomes in Patients with Chronic Kidney Disease

Kate Wilcox, David Preiss

Watch time: 18m 1s
ESC 24: FINE-HEART: Finerenone in HF & CKD

Muthiah Vaduganathan

Watch time: 4m 24s

Articles

Management of Chronic Coronary Disease and Acute Coronary Syndromes in Patients with Chronic Kidney Disease

Karthiek R Narala

,

Thomas A LaLonde

,

Sohail Hassan

,

Peter A McCullough

,

Citation:

US Cardiology 2011;8(2):123–31

DOI:

https://doi.org/10.15420/usc.2011.8.2.123
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 4041
  • Downloads: Downloads 22
  • Citations: 1

Treatment of Hypertension in Patients with Chronic Kidney Disease

Debbie L Cohen

,

Raymond R Townsend

,

Citation:

US Cardiology 2009;6(2):54–8

DOI:

https://doi.org/10.15420/usc.2009.6.2.54
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 12323
  • Downloads: Downloads 18
  • Citations: 4